Antaros Tracer

Antaros Tracer is a specialized biotechnology company focused on the development and validation of novel Positron Emission Tomography (PET) tracers to support drug development. As a sister company to Antaros Medical, it leverages advanced molecular imaging to provide deep mechanistic insights into disease progression and treatment response across metabolic, cardiovascular, and renal diseases. The company's core expertise lies in the design and application of radiolabeled molecules that target specific biological pathways, enabling pharmaceutical partners to visualize drug distribution and target engagement in vivo. By bridging the gap between molecular biology and clinical imaging, Antaros Tracer accelerates the development of precision medicines through quantitative imaging biomarkers.